RxDoctor Payments Data

Alyx Aigen, MD

Dermatology · Miami, FLNPI 1861734584

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,825 of the $15,114 with a category attached, or 71.6%. Sun Pharmaceutical Industries Inc. accounts for 67.7% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $10,713, more than ten times the $418 reported in 2019.

$15,114in general payments, 2019–2025

Across 43 payments — averaging $351.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$10K
  • AbbVie$4K
  • Sanofi$167
  • Fresenius Kabi USA, LLC$167
  • Arcutis Biotherapeutics, Inc.$153
  • Almirall LLC$150
  • plus $657 from 8 others

What the payments were for

  • Consulting fees$10,82572%
  • Speaking & faculty fees$801%
  • Travel & lodging$1,1838%
  • Food & beverage$3,00020%
  • Education$250%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,114 in reported general payments places this provider in the 85th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024
$205,460
Medicare patients
251
Services billed
1,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil21$847
Ketoconazole23$282
Doxycycline Hyclate22$262
Mupirocin24$137

Paid to pharmacies, not to this prescriber.

Other dermatology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →